Dobromiła Osuch, Piotr Zatyka, Adam Słomczyński, Agata Pawłowska, Michal Rabenda, Piotr Janik, & Dominika Opala. (2024). Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease. Nicolaus Copernicus University in Toruń.
Chicago Style (17th ed.) CitationDobromiła Osuch, Piotr Zatyka, Adam Słomczyński, Agata Pawłowska, Michal Rabenda, Piotr Janik, and Dominika Opala. Use of Glucagon-like Peptide 2 (GLP-2) Analogs in Inflammatory Bowel Disease. Nicolaus Copernicus University in Toruń, 2024.
MLA (9th ed.) CitationDobromiła Osuch, et al. Use of Glucagon-like Peptide 2 (GLP-2) Analogs in Inflammatory Bowel Disease. Nicolaus Copernicus University in Toruń, 2024.
Warning: These citations may not always be 100% accurate.